STAT

Opinion: FDA shouldn’t allow politics to hurt women suffering miscarriage

A two-drug regimen would be a game-changer for women experiencing miscarriage — if they could get access to it.
A mifepristone pill

When my obstetrician couldn’t detect a fetal heartbeat during my 9th week of pregnancy, he cleared his schedule. His assistant worked through lunch. They booked an operating room, lined up an anesthesiologist, coordinated insurance approvals, and scheduled a dilation and evacuation procedure for the following morning. It was over by noon. I was able to start healing, emotionally and physically.

I was lucky to get such fast and efficient care. It doesn’t work that way for countless women across the country.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks